O3‐05–04: The 8‐hydroxyquinoline analog PBT2 rapidly restores cognition and reduces soluble Abeta in Alzheimer transgenic mice

Robert A. Cherny, Paul A. Adlard, David I. Finkelstein, Elisabeth Gautier, Penny Huggins, Jack Parsons, Craig W. Ritchie, Elysia Robb, Mikhalina Cortes, Irene Volitakis, Xiang Liu, Jeffrey P. Smith, Keyla Perez, Katrina Laughton, Qiao-Xin Li, Susan A. Charman, Joseph A. Nicolazzo, Simon Wilkins, Karolina Deleva, Gaik Kok, Roberto Cappai, Rudi E. Tanzi, Colin L. Masters, Kevin J. Barnham, Ashley I. Bush, The Mental Health Research Institute of Victoria & The University of Melbourne, Parkville, VIC, Australia; MHRI & The University of Melbourne, Parkville, Australia; Prana Biotechnology Ltd, Parkville, Australia; Imperial College London, London, United Kingdom; MHRI, Parkville, Australia; The University of Melbourne, Parkville, Australia; Centre for Drug Candidate Optimisation, Parkville, Australia; Bio 21 Institute, The University of Melbourne, Parkville, Australia; Genetics & Aging Research Unit, MGH, Boston, MA, USA. Contact e-mail: rcherny@mhri.edu.au